secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2022-11-07T23:59:59+00:00
Accession:  0001801170-22-000082
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health Q3 revenue $856.8M, Insurance MCR improves to 86.3%; updates 2022 guidance
--------------------------------------------------------------------------------

- Total revenue $856.8M more than doubled vs $427.2M YoY; net loss widened to $75.3M from $34.5M.
- Insurance MCR improved to 86.3% in Q3 (vs 102.5% YoY); YTD Insurance MCR 91.7% vs 120.4% YoY.
- Updated 2022 guidance: Insurance MCR range narrowed to 93%-94% (from prior 102%-106%).
- Plans to moderate 2023 Insurance growth to prioritize profitability; reduce ACO REACH physician count.
- Adjusted EBITDA loss narrowed to $58.3M from $79.7M YoY; strong liquidity, no capital need through 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117022000082/0001801170-22-000082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117022000082/clov-20221107.htm
  HTML page:      https://secwatch.observer/filing/0001801170-22-000082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer